References

1 Klöppel G, Luttges J: WHO-classification 2000: exocrine pancreatic tumors. Verh Dtsch Ges Pathol 2001;85:219-231.

2 Kimura W: How many millimeters do atypical epithelia of the pancreas spread intraductally before beginning to infiltrate? Hepatogastroenterology 2003;50:2218-2224.

3 Nakaizumi A, Uehara H, Takenaka A, Uedo N, Sakai N, Yano H, Ohigashi H, Ishikawa O, Ishiguro S, Sugano K, Tatsuta M: Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy. Hepatogastroenterology 1999;46:31-37.

4 Hara H, Suda K, Oyama T: Cytologic study of noninvasive intraductal papillary-mucinous carcinoma of the pancreas. Acta Cytol 2002;46:519-526.

Hara H, Suda K, Oyama T: Two cytologic patterns in invasive ductal adenocarcinoma of the pancreas. Acta Cytol 2005;49:611-620.

Ohhashi K, Murakami Y, Takekoshi K: Four cases of mucous secreting pancreatic cancer (Abstr). Prog Diagn Endosc 1982;20:348-351.

Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: Histological Typing of Tumours of the Exocrine Pancreas. Berlin, Springer-Verlag, World Health Organization, 1996, pp 15-47. Uehara H, Nakaizumi A, Iishi H, Tatsuta M, Kitamura T, Okuda S, Ohigashi H, Ishikawa O, Takenaka A, Ishiguro S: Cytologic examination of pancreatic juice for differential diagnosis of benign and malignant mucin-producing tumors of the pancreas. Cancer 1994;74:826-833. Maire F, Hammel P, Terris B, et al: Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-722.

Raimondo M, Tachibana I, Urrutia R, et al:Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2002;97:2553-2558.

Adsay NV: Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics. J Gastrointest Surg 2002;6:656-659.

Fukushima N, Mukai K, Kanai Y, et al: Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol 1997;28:1010-1017. Milchgrub S, Campuzano M, Cassillas J, Albores-Saavedra J: Intraductal carcinoma of the pancreas. Cancer 1992;69:651-656.

Kameya S, Noda A, Kato H, Hotta S, Hara K, Sugiura H, Mizuno Y: Cytologic feature of mucin producing pancreatic tumor. J Jpn Soc Clin Cytol 1989;28:431-437.

Iwao T, Tsuchida A, Handa K, Eguchi N, Kajiyama G, Shimamoto F: Immunocytochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumors of the pancreas, Cancer Cytopathol 1997;81:163-171.

Inoue H, Thuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G: Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer 2001;91:35-41.

Tomaszewska R, Popiela T, Karcz D, Nowak K, Stachura J: Infiltrating carcinoma arising in intra-ductal papillary-mucinous tumor of the pancreas. Diagn Cytopathol 1998;18:445-448. Shimizu M, Hirokawa M, Manabe T, Mikami Y, Kanahara T, Miyake Y, Iwamoto S, Tsunoda T: Cytologic findings in noninvasive intraductal papillary-mucinous carcinoma of the pancreas; a report of two cases. Acta Cytol 1999;43:243-246.

Al-Kaisi, Siegler EE: Fine needle aspiration cytology of the pancreas. Acta Cytol 1989;33: 145-152.

Robins DB, Ruth LK, Douglas BE, E Neely A, Kinda G: Fine needle aspiration of the pancreas: in quest of accuracy. Acta Cytol 1995;39:1-10.

Cohen MB, Egerter DP, Holly EA, Ahn DK, Miller TR: Pancreatic adenocarcinoma: regression analysis to identify improved cytologic criteria. Diagn Cytopathol 1991;7:341-345. Morohoshi T, Kanda M, Asanuma K, Klöppel G: Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 1989;64:1329-1335.

Solcia E, Capella C, Klöppel G: Tumors of the Pancreas. Atlas of Tumor Pathology, 3rd series, Fascicle 20. Washington, D.C., Armed Forces Institute of Pathology, 1997, pp 53-87, 226-231. Nakamura A, Horinouchi M, Goto M, et al: New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol 2002;197:201-210.

Yonezawa S, Horinouchi M, Osako M, et al: Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor. Pathol Int 1999;49:45-54. Adsay NV, Adair CF, Heffess CS, et al: Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996;20:980-994.

Adsay NV Conlon KC, Zee SY, et al: Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinoma in 28 patients. Cancer 2002;94:62-77. Matsuzawa K, Akamatsu T, Katsuyama T: Mucin histochemistry of pancreatic duct cell carcinoma, with special reference to organoid differentiation simulating gastric pyloric mucosa. Hum Pathol 1992;23:925-933.

Culling CFA, Reid PE, Worth AW: Carbohydrate markers in the lower gastrointestinal tract. Methods Achiev Exp Pathol 1981;10:73-100.

Culling CFA, Reid PE, Clay MC, et al: The histochemical demonstration of O-acylated sialic acid in gastrointestinal mucins: their association with the potassium hydroxide-periodic acid-Schiff effect. J Histochem Cytochem 1974;22:826-831.

Yamasaki S, Suda K, Nobukawa B, Sonoue H: Intraductal spread of the pancreatic cancer: clinicopathologic study of 54 pancreatectomized patients. Pancreatology 2002;2:407-412. Cubilla AL, Fitzgerald PJ: Benign neoplasms, malignant neoplasms. Tumor of the exocrine pancreas; in: Atlas of Tumor Pathology, 2nd series, Fascicle 19. Washington, D.C., Armed Forces Institute of Pathology, 1984, pp 139-140.

Cubilla AL, Fitzgerald PJ: Morphological lesions associated with human primary invasive nonendcrine pancreas cancer. Cancer Res 1976;36:2690-2698.

Klöppel G, Bommer G, Ruckert K, Seifert G: Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch Pathol Anat 1980;387:221-233. Furukawa T, Chiba R, Kobari M, Matsuno S, Nagura H, Takahashi T: Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch Pathol Lab Med 1994;118:227-234.

Andea A, Sarkar F, Adsay NV: Clinicopathological correlates of pancreatic intraepithelial neopla-sia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarci-noma. Mod Pathol 2003;16:996-1006.

Kozuka S, Sassa R, Taki T, et al: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418-1428.

Lüttges J, Reinecke-Luthge A, Mollman B, et al: Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 1999;435: 461-468.

Pour PM, Sayed S, Sayed G: Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol 1982;77:137-152.

Hruban RH, Takaori K, Klimstra DS, Adsay NV Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Klöppel G, Longnecker DS, Lüttges J, Maitra A, Offerhaus JA, Shimizu M, Yonezawa S: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987.

Uehara H, Nakaizumi A, Tatsuta M, Iishi H, Kitamura T, Ohigashi H, Ishikawa O, Takanaka A: Diagnosis of carcinoma in situ of the pancreas by peroral pancreatoscopy and pancreatoscopic cytology. Cancer 1997;79:454-461.

Adsay NV, Longnecker DS, Klimstra DS: Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 2000;17:16-30.

Hruban RH, Adsay NV Albores-Saavedra J, et al: Pancreatic intraepithelial neoplasia (PanIN): a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.

Sato N, Ueki T, Fukushima N, et al: Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002;123:365-372. Soldini D, Gugger M, Burckhardt E, et al: Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts. J Pathol 2003;199:453-461.

Mukai S, Nakajima M, Yasuda K, Syou E, Ashihara T, Hirano S, Motiduki N, Tanaka S, Uno K, Tojo M, Tomioka H, Yazaki T, Tsukada K, Ueda M, Miyata M, Kato G: A case report of carcinoma in situ. Panc Bil Tract 1996;17:1103-1106.

Murakami I, Nishimura T, Kiyohiro M, Sato M, Hoshida Y: A case of pancreas cancer (carcinoma in situ) diagnosed by pancreatic juice cytology. J Jpn Soc Clin Cytol 1995;36:652-653. Nakaizumi A, Tatsuta M, Uehara H, Takenaka A, Ohigashi H, Ishikawa O, Ishiguro S: Usefulness of simple endoscopic aspiration cytology of pancreatic juice for diagnosis of early pancreatic neoplasm: a prospective study. Dig Dis Sci 1997;42:1796-1803.

Nakaizumi A, Tatsuta M, Uehara H, Takenaka A, Ishii H, Kitamura T, Ohigashi H, Ishikawa O, Okuda S, Wada A: Effectiveness of the cytologic examination of pure pancreatic juice in the diagnosis of early neoplasia of the pancreas. Cancer 1995;75:750-757. Yamada T: Cytopathologic Diagnostics. Tokyo, Bunkodo, 1995, pp 56, 107-108. Layfield LJ, Wax TD, Lee JG, Cotton PB: Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol 1995;39:11-18.

Al-Kaisi N, Siegler EE: Fine needle aspiration cytology of the pancreas. Acta Cytol 1989;33: 145-152.

Monzat V, Fanjul M, Leclerc C, Palevody C, Briand JP, Jarry-Guichard T, Gabrion J, Moreau M, Hollande E: Progressive development of gap junctions during growth of human pancreatic duct cells (Capan-1) in vitro and in vivo. Biol Cell 1995;85:157-165.

Obara T, Saitoh Y, Maguchi H, Ura H, Kitazawa S, Koike Y, et al: Multicentric development of pancreatic intraductal carcinoma through atypical hyperplasia. Hum Pathol 1992;23:82-85. Fujii T, Obara T, Maguchi H, Tanno, S, Ura H, Kohgo Y: Clinicopathologic study of multiple mucin-producing tumors of the pancreas: multicentric development of carcinoma through atypical hyperplasia [in Japanese]. J Jpn Pancreat Soc 1996;11:344-352.

Inagaki M, Maguchi M, Kino S, Obara M, Ishizaki A, Onodera K, et al: Mucin-producing tumors of the pancreas: clinicopathological features, surgical treatment, and outcome. J Hepatobil Pancreat Surg 1999;6:281-285.

Fujii H, Inagaki M, Kasai S, Miyokawa N, Tokusashi Y, Gabrielson E, et al: Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997;151:1447-1454.

Yanagisawa A, Ohtaki K, Ohashi K, Hori M, Kitagawa T, Sugano H, et al: Frequent c-Ki-ras onco-gene activation in mucinous cell hyperplasia of the pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-956.

Yanagisawa A, Kato Y, Ohtaki K, Kitagawa T, Ohashi K, Hori M, et al: c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 1991;82: 1056-1060.

Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, et al: Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and k-ras, p53, and c-erbB-2 abnomalities in 26 patients. Virchows Arch 1994;425:357-367. Z'graggen K, Rivera JA, Compton CC, Pins M, Werner J, Fernandez-del Castillo C, et al: Prevalence of activating k-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997;226:491-500.

Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y: Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer 2001;92:1807-1817. Tomaszewska R, Karcz D, Stachura J: An immunohistochemical study of the expression of bcl-2 and p53 oncoproteins in pancreatic intraepithelial neoplasia and pancreatic cancer. Int J Pancreatol 1999;26:163-171.

Boschman CR, Stryker S, Reddy JK, Rao MS: Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol 1994;145:1291-1295.

Terada T, Ohta T, Kitamura Y, Ashida K, Matsunaga Y: Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immuno-histochemical study. Arch Pathol Lab Med 1998;122:42-46.

Kuwano H, Saeki H, Kawaguchi H, Sonoda K, Kitamura K, Nakashima H, Tou Y, Sugimachi K: Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous-cell carcinoma. Int J Cancer 1998;78:149-152.

Zaitoun AM, Ebbs SR: Quantitative cytological assessment of Ki67 and AgNORs using computer-digitized image analysis of four clinicopathological breast lesions. Cytopathology 2000;11:243-254. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that Dpc4 inactivation occurs late in neoplastic progression. Cancer Res 2000;60:2002-2006. Klöppel G, Lohse T, Bosslet K, Ruckert K: Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line. Histological and immunocy-tochemical analysis of 37 total pancreatectomy specimens. Pancreas 1987;2:170-175.

70 Klöppel G, Lingenthal G, von Bulow M, Kern HF: Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: Studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology 1985;9:841-856.

71 Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV Hruban RH, Goodmann SN, Deeley WC, Coleman J, Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas. Ann Surg 1995;221:721-731.

72 Trede M, Schwall G, Saeger HD: Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-458.

73 Tsunoda T, Ura K, Eto T, Matsumoto T, Tsuchiya R: UICC and Japanese stage classifications for carcinoma of the pancreas. Int J Pancreatol 1991;8:205-214.

74 Luttges J, Hahn S, Kloppel G: Where and when does pancreatic carcinoma start? Med Klin (Munich) 2004;99:191-195.

75 Ishikawa O, Imaoka S, Ohigashi H, Nakaizumi A, Uehara H, Wada A, Nagumo S, Yamamoto R, Sasaki Y, Iwanaga T: A new method of intraoperative cytodiagnosis for more precisely locating the occult neoplasms of the pancreas. Surgery 1992;111:294-300.

76 Ishikawa O, Ohigashi H, Nakaizumi A, Uehara H, Kitamura T, Takenaka A, Sasaki Y, Imaoka S: Surgical resection of potentially curable pancreatic cancer with improved preservation of endocrine function-further evaluation of intraoperative cytodiagnosis. Hepatogastroenterology 1993;40:443-447.

77 Ishikawa O, Ohigashi H, Nakamori S, Sasaki Y, Furukawa H, Imaoka S, Iwanaga T, Nakaizumi A: Three-segmental cytodiagnosis using ballon-catheter for locating occult carcinoma of the pancreas. J Am Coll Surg 1995;180:353-355.

78 Ishikawa O, Ohigashi H, Imaoka S, takenaka A, Uehara H, Nakaizumi A: Surgical techniques of cytology-guided pancreatectomy for occult neoplasm of the pancreas. Hepatogastroenterology 1995;42:724-729.

79 Ishikawa O, Ohigashi H, Yamada T, Sasaki T, Imaoka S, Nakaizumi A, Uehara H, Tanaka S, Takenaka A: Radical resection for pancreatic cancer. Acta Gastroenterol Belge 2002;65:166-170.

Hitoshi Hara

Department of Biochemistry, Akebono Medical Welfare Center 3313-1, Kamijo Minamiwari, Asahimachi Nirasaki City 407-0046 (Japan)

Tel. +81 551 22 6111 (ext. 241 or 243); Fax +81 551 22 7890, E-Mail [email protected]

Was this article helpful?

0 0

Post a comment